Yokogawa Electric Establishes Consortium to Develop Manufacturing Automation Platform for Regenerative Medicine Products
Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.
📋 Article Processing Timeline
- 📰 Published: April 13, 2026 at 11:10
- 🔍 Collected: April 13, 2026 at 12:51 (1h 41m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 15:56 (3h 4m after Collected)
Founded in 1915, Yokogawa Electric boasts a global network spanning 60 countries with over 17,000 employees. As the YOKOGAWA Group, it contributes to solving societal issues by leveraging its expertise in measurement, control, and information technologies. In its core "control business," the company has pioneered distributed control systems and autonomous control AI for plant production equipment, supporting industrial development in sectors such as energy, chemicals, materials, pharmaceuticals, and food. This new consortium focuses on developing an automation platform for regenerative medicine products.